|
Variables
|
Observation
|
HR
|
95%CI
|
p value of Q
|
I2 (%)
|
Tau2
|
Q-statistic
|
P value of estimate
|
|---|
|
Functional status
| |
|
Working (ref)
|
4
|
1
| | | | | | |
|
Ambulatory
|
1.46
|
[0.84, 2.51]
|
p = 0.001
|
78.8
|
0.29
|
18.83
|
p = 0.18
|
|
Bedridden
|
2.01
|
[1.21, 3.35]
|
p = 0.137
|
42.7%
|
0.13
|
6.98
|
p = 0.007
|
|
Anemia status
| |
|
Not anemic (ref)
|
8
|
1
| | | | | |
p < 0.001
|
|
Anemic
|
2.30
|
[1.75, 3.02]
|
p = 0.179
|
31.2
|
0.05
|
10.17
|
|
WHO clinical staging
| |
|
Stage I/II (ref)
|
10
|
1
| | | | | |
p < 0.001
|
|
Stage III/IV
|
2.26
|
[1.70, 3.02]
|
p = 0.048
|
47.2
|
0.09
|
17.05
|
|
Cotrimoxazole preventive therapy
| |
|
Yes(ref)
|
5
|
1
| | | | | |
p = 0.007
|
|
No
|
2.16
|
[1.23, 3.72]
|
p = 0.062
|
55.3
|
0.20
|
8.95
|
|
Isoniazid preventing therapy
| |
|
Yes (ref)
|
7
|
1
| | | | | |
p = 0.001
|
|
No
|
3.67
|
[1.73, 7.76]
|
p < 0.001
|
79.1
|
0.74
|
28.7
|
|
CD4 cell count
| |
|
Greater than 200
|
6
|
1
| | | | | |
p = 0.002
|
|
Less than or equal to 200
|
2.12
|
[1.31, 3.43]
|
p < 0.001
|
90.8
|
0.32
|
54.38
|
|
Previous history of tuberculosis
| |
|
No
|
3
|
1
| | | | | | |
|
Yes
|
1.49
|
[0.77, 2.89]
|
p = 0.004
|
73.5
|
0.39
|
15.11
|
p = 0.24
|
|
Gender
| |
|
Female
|
5
|
1
| | | | | | |
|
Male
|
1.37
|
[1.16, 1.63]
|
p = 0.588
|
0
|
0
|
2.82
|
p < 0.001
|
|
Family size
|
|
Less than five
| |
1
| | | | | | |
|
Five or more
|
3
|
1.18
|
[0.89, 1.56]
|
p = 0.29
|
19.0
|
0.01
|
2.47
|
p = 0.26
|
